No Data
Buy Recommendation for Cartesian Therapeutics on Robust Clinical Trials and Favorable Regulatory Prospects
HC Wainwright & Co. Maintains Buy on Cartesian Therapeutics, Lowers Price Target to $45
Oppenheimer Sticks to Their Hold Rating for Cartesian Therapeutics (RNAC)
Buy Rating Affirmed for Cartesian Therapeutics Amid Clinical Success and Strengthened Financials
Express News | Needham Maintains Buy on Cartesian Therapeutics, Lowers Price Target to $41
Express News | Cartesian Therapeutics Inc : Needham Cuts Target Price to $41 From $42
andy(三叔) : $Chicken Soup for the Soul Entertainment (CSSE.US)$ $Chicken Soup For The Soul Entmt Inc 9.50% Notes Due 2025 Usd25 (CSSEN.US)$ $Chicken Soup for the Soul Entertainment Inc (CSSEP.US)$
Trytosaveabit OP andy(三叔) : It’s a bankruptcy play from Redbox filing for protection!